SXTC — China SXT Pharmaceuticals Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for China SXT Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-2.75	-5.74	-5.93	-3.1	-3.3
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	2.89	2.89	4.19	1.35	1.85
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-1.61	2.46	1.42	-0.382	-0.972
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	-1.32	0.268	-0.081	-1.93	-2.35
Capital Expenditures	-0.093	-0.062	-0.071	-0.007	-0.002
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-5.71	0.016	0.058	0.033	0.066
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-5.81	-0.047	-0.012	0.026	0.064
Financing Cash Flow Items	12.5	-3.84	-3.26	-1.73	5.84
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	12.4	1.6	2.94	-2.62	8.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	6.07	2.21	1.8	-5.29	6.05